Akari Therapeutics PLC (AKTX) Insider Trading
Total insider buys:
- $1,056,994.13
Total insider sells:
- $0.00
Most recent insider trade:
- Sept. 18, 2015
Most active insider trader:
- Sabby Management, Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 18, 2015 | Director | 1,055,600 | $0.19 | Buy | $200,564.00 | |
| April 15, 2014 | Major Shareholder | 20,100 | $5.03 | Buy | $101,103.00 | |
| April 11, 2014 | Major Shareholder | 2,575 | $5.35 | Buy | $13,776.25 | |
| April 8, 2014 | Major Shareholder | 68,404 | $5.59 | Buy | $382,378.36 | |
| April 2, 2014 | Major Shareholder | 28,207 | $6.22 | Buy | $175,447.54 | |
| March 27, 2014 | Major Shareholder | 16,203 | $6.66 | Buy | $107,911.98 | |
| March 24, 2014 | Major Shareholder | 11,100 | $6.83 | Buy | $75,813.00 |
First«1 of 1»Last
Insiders are buying Akari Therapeutics PLC stock.
The insider traders at Akari Therapeutics PLC are: Sabby Management, Llc, and Mark S Cohen
The most active insider trader at Akari Therapeutics PLC is Sabby Management, Llc with 6 trades.
Sabby Management, Llc has bought the most Akari Therapeutics PLC stock with a total value of $957,533.13.
The most recent insider trade for Akari Therapeutics PLC was on Sept. 18, 2015.
The single biggest insider buy for Akari Therapeutics PLC was from Sabby Management, Llc with a total value of $382,378.36 on April 8, 2014.